THE Department of Health, Disability and Ageing has advised that PBS restrictions have been changed to allow fixed dose combinations (FDCs) for dual therapy antihypertensives to be used as a first-line treatment for hypertension in line with international clinical guidelines.
On 01 Apr, 30-day prescription items for antihypertensive dual therapy FDCs were changed to Unrestricted Benefit listings, while 60day prescription items were changed to Restricted Benefit listings in stable patients - learn more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Apr 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Apr 26
